Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year πŸ† (Miller School of Medicine, 2015), the Outstanding Care Award πŸ… (Sarcoma Alliance, 2012), and the Leadership in Clinical Research πŸŽ–οΈ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Mr Admasu Gizaw, Jimma University, Ethiopia

Admasu Gizaw, MScN, Ph.D. FellowπŸŽ“πŸ©Ί is an esteemed nursing educator and researcher at Jimma University, Ethiopia. With an MSc in Adult Health Nursing (2010) and currently pursuing a Ph.D. in Nursing, his research focuses on patient-centered care and nursing standards. He has over 14 years of experience, serving as a lecturer, CPD officer, and program coordinator. His expertise spans mentorship, curriculum development, and systematic reviews. A dedicated contributor to national nursing policies, he has authored impactful studies on public health and nursing practice. Proficient in statistical software πŸ“Š, he actively advances Ethiopia’s healthcare education and nursing profession. πŸš‘πŸ“š

Publication Profile

Scopus

Education

Admasu Gizaw πŸŽ“ is an experienced nursing professional specializing in Adult Health Nursing (Medical-Surgical Nursing). He earned his MScN from Jimma University in 2010, focusing on nurses’ intention to stay in the profession πŸ₯. Currently, he is a Ph.D. Fellow in Nursing at Jimma University (since 2023), researching person-centered nursing care and its outcomes in Ethiopian university hospitals πŸ’‘. His journey began with a BScN in Nursing from Jimma University (2004-2006) 🩺. With a strong academic and research background, he is dedicated to improving nursing care and fostering better healthcare environments in Ethiopia 🌍.

Experience

Admasu Gizaw is a dedicated nursing professional with extensive experience in surgical and academic settings πŸ₯πŸ‘¨β€βš•οΈ. He began his career as a staff nurse in the operating theatre (2003-2004 E.C) before advancing to head nurse (2004-2005 E.C) and later serving as Vice Nursing Service Director at JUMC (2007-2008 E.C) 🌟. He also worked as Delegate Nursing Service Director (Dec-June 2008 E.C). With over nine years as a lecturer and Assistant Professor at Jimma University (since May 2016) πŸŽ“, he coordinated the Operation Theatre Nursing Specialty Program (2017-2020) and currently serves as CPD Officer at Jimma University Institute of Health (since Feb 2023) πŸ“š.

Certificate Awarded Training

Mr. Admasu Gizaw has made significant contributions to the nursing field in Ethiopia, particularly in course development and training. Notably, he has developed and trained courses on Safe Operation Theatre, Nursing Documentation and Reporting, Wound Care, Body Fluid Management, and Nursing Process Application for organizations like Jimma University, Ethiopian Nurses Association, and the Ministry of Health. His work includes the preparation of national nursing standards, undergraduate program guidelines, and licensure examination blueprints. Mr. Gizaw has also been involved in the development of nursing curricula and earned certificates of contribution and recognition from various prestigious institutions. πŸŽ“πŸ©ΊπŸ“šπŸ‡ͺπŸ‡Ή

Research Focus

Admasu Gizaw’s research primarily focuses on public health issues, particularly in low-resource settings. His studies examine global and regional health burdens, with specific attention to allergic disorders, meningitis, reproductive health, and chronic conditions like hypertension. He has contributed significantly to understanding the risk factors and prevalence of various diseases, including cancer and labor induction. His work also delves into the predictors of moral distress among healthcare workers and factors affecting health service utilization, especially in Ethiopian populations. Gizaw’s research aims to improve healthcare delivery and policy through evidence-based insights. πŸ“ŠπŸŒπŸ©ΊπŸ’‰

Publication Top Notes

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Predictors of Induction of Labor and Success Rate Among Mothers Giving Birth at Jimma University Medical Centre South West Ethiopia: Unmatched Case Control Study

Lifestyle modification practices and associated factors among hypertensive patients at Gambella Hospital Southwest Ethiopia; 2019

Predictors of moral distress among nurses working in Jimma University Medical Center, South West Ethiopia

Cancer Warning Symptoms Awareness and Associated Factors Among Individuals Living in Assella Town, Ethiopia

Reproductive health service utilization and associated factors among adolescents at public school in Adama Town east Shewa Ethiopia, 2018